Literature DB >> 9351116

Repeat intra-arterial papaverine for recurrent cerebral vasospasm after subarachnoid haemorrhage.

Y Numaguchi1, G H Zoarski, J E Clouston, M T Zagardo, J M Simard, E F Aldrich, M A Sloan, P K Maurer, S H Okawara.   

Abstract

We assessed the prevalence of recurrent vasospasm following failure of intra-arterial papaverine and the efficacy of repeat intra-arterial infusions of papaverine for control of recurrent vasospasm. Of 24 patients treated with intra-arterial papaverine for vasospasm following aneurysm surgery, 12 did not improve clinically after the initial treatment; 9 received second or third infusions on consecutive days; 6 received only a second infusion; and 3 received a third. Superselective infusion into the intracranial arteries was performed in all nine cases. Despite angiographic improvement after the initial or second infusions, all nine patients showed varying degrees of recurrent vasospasm at the time of the second or third treatment. Within 24 h of a second infusion, three of the six patients had significant clinical improvement, and one of these showed marked improvement soon after a third infusion. Our preliminary results suggest that repeat papaverine infusion may be a way of controlling recurrent or recalcitrant vasospasm.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351116     DOI: 10.1007/s002340050501

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  8 in total

Review 1.  Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage.

Authors:  James K Liu; William T Couldwell
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Assessment of changes in cerebral circulation time due to vasospasm in a specific arterial territory: effect of angioplasty.

Authors:  B Turowski; R du Mesnil de Rochemont; J Beck; J Berkefeld; F E Zanella
Journal:  Neuroradiology       Date:  2005-02-10       Impact factor: 2.804

3.  Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm.

Authors:  Neeraj Badjatia; Mehmet A Topcuoglu; Johnny C Pryor; James D Rabinov; Christopher S Ogilvy; Bob S Carter; Guy A Rordorf
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

4.  Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results.

Authors:  Alessandra Biondi; Giuseppe K Ricciardi; Louis Puybasset; Lamine Abdennour; Marcello Longo; Jacques Chiras; Rémy Van Effenterre
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

5.  Intraarterial nimodipine infusion to treat symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Jong Hoon Kim; In Sung Park; Kyung Bum Park; Dong-Ho Kang; Soo Hyun Hwang
Journal:  J Korean Neurosurg Soc       Date:  2009-09-30

6.  Current status of endovascular treatment for vasospasm following subarachnoid hemorrhage: analysis of JR-NET2.

Authors:  Kentaro Hayashi; Tomohito Hirao; Nobuyuki Sakai; Izumi Nagata
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-11-21       Impact factor: 1.742

7.  Angiographic features and clinical outcomes of intra-arterial nimodipine injection in patients with subarachnoid hemorrhage-induced vasospasm.

Authors:  Sang-Shin Kim; Dong-Hyuk Park; Dong-Jun Lim; Shin-Hyuk Kang; Tai-Hyoung Cho; Yong-Gu Chung
Journal:  J Korean Neurosurg Soc       Date:  2012-09-30

8.  Clinical Variables Correlated with Numbers of Intra-arterial Nimodipine Infusion in Patients with Medically Refractory Cerebral Vasospasm.

Authors:  Sang-Young Kim; Ki-Hong Kim; Jae-Hoon Cho; Young-Don Kim
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2015-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.